Literature DB >> 9219057

Comparison of three methods for 17 alpha-hydroxyprogesterone.

V D Castracane1, T Gimpel.   

Abstract

We compared the performance of three 17 alpha-hydroxyprogesterone kits: the double antibody method, the coated tube method (ACTIVE), both from Diagnostic Systems Laboratories, Inc. (DSL) and the coated tube method (COAT-A-COUNT) from Diagnostic Products Corporation (DPC). The assay performance of the two DSL kits was very similar in terms of sensitivity, intra- and inter-assay precision, linearity of dilution, recovery, and specificity. We also analyzed 190 samples for 17 alpha-hydroxyprogesterone values using the above three kits. Twenty-three subjects were from prepubertal population (ages 1 month-13 years), thirty subjects were normal adult males (ages 20-53 years) and the remaining subjects were females in different phase of menstrual cycle (n = 40), on oral contraceptives (n = 20), post-menopausal (n = 17), or pregnant women in their first, second, or third trimester (n = 60). In addition to these 60 pregnancy samples, we analyzed serial samples from 3 pregnancies. 17 alpha-OHP levels paralleled the progesterone levels in all three kits. Although there was reasonable correlation between the DPC and the two DSL kits, the 17 alpha-OHP values were found to be significantly higher with DPC kit during the 2nd and 3rd trimester of pregnancy indicating probable interference in the DPC assay by some structurally related steroids present during pregnancy. The DSL assays may be particularly well suited for measuring 17 alpha-OHP levels during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219057      PMCID: PMC6760693          DOI: 10.1002/(sici)1098-2825(1997)11:4<179::aid-jcla1>3.0.co;2-4

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  19 in total

1.  Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia.

Authors:  S Pang; J Hotchkiss; A L Drash; L S Levine; M I New
Journal:  J Clin Endocrinol Metab       Date:  1977-11       Impact factor: 5.958

2.  17-Hydroxyprogesterone in normal children and congenital adrenal hyperplasia. Measurement in serum by radioimmunoassay after thin-layer chromatography.

Authors:  K E Petersen; T Christensen
Journal:  Acta Paediatr Scand       Date:  1979-03

3.  The relation of serum 17-hydroxyprogesterone and estradiol-17-beta levels during the human menstrual cycle.

Authors:  I H Thorneycroft; D R Mishell; S C Stone; K M Kharma; R M Nakamura
Journal:  Am J Obstet Gynecol       Date:  1971-12-01       Impact factor: 8.661

4.  A pilot newborn screening for congenital adrenal hyperplasia in Alaska.

Authors:  S Pang; W Murphey; L S Levine; D A Spence; A Leon; S LaFranchi; A S Surve; M I New
Journal:  J Clin Endocrinol Metab       Date:  1982-09       Impact factor: 5.958

5.  Congenital adrenal hyperplasia.

Authors:  M I New; L S Levine
Journal:  Monogr Endocrinol       Date:  1984

6.  Production and characterization of monoclonal antibodies to 17 alpha-hydroxyprogesterone.

Authors:  J Sawada; T Terao; S Itoh; M Maeda; A Tsuji; H Hosoda; T Nambara
Journal:  J Steroid Biochem       Date:  1987-10       Impact factor: 4.292

7.  Sex differences in corticosteroids in man.

Authors:  M Schöneshöfer; G G Wagner
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

8.  Plasma levels of aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone during infancy and childhood.

Authors:  W G Sippell; H G Dörr; F Bidlingmaier; D Knorr
Journal:  Pediatr Res       Date:  1980-01       Impact factor: 3.756

9.  The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia.

Authors:  I A Hughes; J S Winter
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

10.  Neonatal screening for congenital adrenal hyperplasia: a programme based on a novel direct radioimmunoassay for 17-hydroxyprogesterone in blood spots.

Authors:  A M Wallace; G H Beastall; B Cook; A J Currie; A M Ross; R Kennedy; R W Girdwood
Journal:  J Endocrinol       Date:  1986-02       Impact factor: 4.286

View more
  1 in total

1.  Rapid screening assay of congenital adrenal hyperplasia by measuring 17 alpha-hydroxyprogesterone with high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots.

Authors:  Chien-Chen Lai; Chang-Hai Tsai; Fuu-Jen Tsai; Jer-Yuarn Wu; Wei-De Lin; Cheng-Chun Lee
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.